Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 373 to 384 of 403 entries
Sorted by: Best Match Show Resources per page
Stroke during induction of labour in a patient with carotid aneurysm and prior multiple venous thromboses.

Obstetric medicine

Datta S, Stern JS, Williams B.
PMID: 27582816
Obstet Med. 2009 Jun;2(2):75-6. doi: 10.1258/om.2008.080050. Epub 2009 May 22.

A case of stroke during induction of labour in a pregnant patient at term anticoagulated for prior venous thrombosis is reported. The cause was a middle cerebral artery embolism, originating from a false dissecting aneurysm of the internal carotid...

Cite
Datta S, Stern JS, Williams B. Stroke during induction of labour in a patient with carotid aneurysm and prior multiple venous thromboses. Obstet Med. 2009;2(2):75-6doi: 10.1258/om.2008.080050.
Datta, S., Stern, J. S., & Williams, B. (2009). Stroke during induction of labour in a patient with carotid aneurysm and prior multiple venous thromboses. Obstetric medicine, 2(2), 75-6. https://doi.org/10.1258/om.2008.080050
Datta, Sujata, et al. "Stroke during induction of labour in a patient with carotid aneurysm and prior multiple venous thromboses." Obstetric medicine vol. 2,2 (2009): 75-6. doi: https://doi.org/10.1258/om.2008.080050
Datta S, Stern JS, Williams B. Stroke during induction of labour in a patient with carotid aneurysm and prior multiple venous thromboses. Obstet Med. 2009 Jun;2(2):75-6. doi: 10.1258/om.2008.080050. Epub 2009 May 22. PMID: 27582816; PMCID: PMC4989721.
Copy Download .nbib Format: NLM
Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome.

Journal of market access & health policy

François C, Stern JM, Ogbonnaya A, Lokhandwala T, Landsman-Blumberg P, Duhig A, Shen V, Tan R.
PMID: 28740620
J Mark Access Health Policy. 2017 May 19;5(1):1318691. doi: 10.1080/20016689.2017.1318691. eCollection 2017.

No abstract available.

Cite
François C, Stern JM, Ogbonnaya A, et al. Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome. J Mark Access Health Policy. 2017;5(1):1318691doi: 10.1080/20016689.2017.1318691.
François, C., Stern, J. M., Ogbonnaya, A., Lokhandwala, T., Landsman-Blumberg, P., Duhig, A., Shen, V., & Tan, R. (2017). Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome. Journal of market access & health policy, 5(1), 1318691. https://doi.org/10.1080/20016689.2017.1318691
François, Clément, et al. "Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome." Journal of market access & health policy vol. 5,1 (2017): 1318691. doi: https://doi.org/10.1080/20016689.2017.1318691
François C, Stern JM, Ogbonnaya A, Lokhandwala T, Landsman-Blumberg P, Duhig A, Shen V, Tan R. Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome. J Mark Access Health Policy. 2017 May 19;5(1):1318691. doi: 10.1080/20016689.2017.1318691. eCollection 2017. PMID: 28740620; PMCID: PMC5508372.
Copy Download .nbib Format: NLM
Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?.

Transgender health

Nelson MD, Szczepaniak LS, Wei J, Szczepaniak E, Sánchez FJ, Vilain E, Stern JH, Bergman RN, Bairey Merz CN, Clegg DJ.
PMID: 29159307
Transgend Health. 2016 Aug 01;1(1):165-171. doi: 10.1089/trgh.2016.0016. eCollection 2016.

No abstract available.

Cite
Nelson MD, Szczepaniak LS, Wei J, et al. Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?. Transgend Health. 2016;1(1):165-171doi: 10.1089/trgh.2016.0016.
Nelson, M. D., Szczepaniak, L. S., Wei, J., Szczepaniak, E., Sánchez, F. J., Vilain, E., Stern, J. H., Bergman, R. N., Bairey Merz, C. N., & Clegg, D. J. (2016). Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?. Transgender health, 1(1), 165-171. https://doi.org/10.1089/trgh.2016.0016
Nelson, Michael D, et al. "Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?." Transgender health vol. 1,1 (2016): 165-171. doi: https://doi.org/10.1089/trgh.2016.0016
Nelson MD, Szczepaniak LS, Wei J, Szczepaniak E, Sánchez FJ, Vilain E, Stern JH, Bergman RN, Bairey Merz CN, Clegg DJ. Transwomen and the Metabolic Syndrome: Is Orchiectomy Protective?. Transgend Health. 2016 Aug 01;1(1):165-171. doi: 10.1089/trgh.2016.0016. eCollection 2016. PMID: 29159307; PMCID: PMC5685281.
Copy Download .nbib Format: NLM
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.

Annals of clinical and translational neurology

Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A, Trojanowski JQ, Chen-Plotkin AS.
PMID: 27231704
Ann Clin Transl Neurol. 2016 Mar 29;3(5):346-55. doi: 10.1002/acn3.299. eCollection 2016 May.

OBJECTIVE: Cognitive decline occurs in multiple neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD). Shared underlying mechanisms may exist and manifest as shared biomarker signatures. Previously, we nominated plasma epidermal growth factor (EGF) as a biomarker predicting...

Cite
Lim NS, Swanson CR, Cherng HR, et al. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Ann Clin Transl Neurol. 2016;3(5):346-55doi: 10.1002/acn3.299.
Lim, N. S., Swanson, C. R., Cherng, H. R., Unger, T. L., Xie, S. X., Weintraub, D., Marek, K., Stern, M. B., Siderowf, A., Trojanowski, J. Q., & Chen-Plotkin, A. S. (2016). Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Annals of clinical and translational neurology, 3(5), 346-55. https://doi.org/10.1002/acn3.299
Lim, Nicholas S, et al. "Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease." Annals of clinical and translational neurology vol. 3,5 (2016): 346-55. doi: https://doi.org/10.1002/acn3.299
Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A, Trojanowski JQ, Chen-Plotkin AS. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Ann Clin Transl Neurol. 2016 Mar 29;3(5):346-55. doi: 10.1002/acn3.299. eCollection 2016 May. PMID: 27231704; PMCID: PMC4863747.
Copy Download .nbib Format: NLM
Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?.

Movement disorders clinical practice

Chahine LM, Stern MB.
PMID: 30363472
Mov Disord Clin Pract. 2017 Oct 02;4(6):796-805. doi: 10.1002/mdc3.12545. eCollection 2017.

BACKGROUND: Objective measures of Parkinson's disease (PD) are needed for purposes of diagnosis and prognostication, as well as identification of those at risk of PD. In this qualitative review, we provide an overview of the current state of the...

Cite
Chahine LM, Stern MB. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?. Mov Disord Clin Pract. 2017;4(6):796-805doi: 10.1002/mdc3.12545.
Chahine, L. M., & Stern, M. B. (2017). Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?. Movement disorders clinical practice, 4(6), 796-805. https://doi.org/10.1002/mdc3.12545
Chahine, Lana M, and Stern, Matthew B. "Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?." Movement disorders clinical practice vol. 4,6 (2017): 796-805. doi: https://doi.org/10.1002/mdc3.12545
Chahine LM, Stern MB. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?. Mov Disord Clin Pract. 2017 Oct 02;4(6):796-805. doi: 10.1002/mdc3.12545. eCollection 2017. PMID: 30363472; PMCID: PMC6174521.
Copy Download .nbib Format: NLM
Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection.

Hepatology research : the official journal of the Japan Society of Hepatology

Nishiguchi S, Urano Y, Suzaki K, Taniguchi A, Scherer J, Berger KL, Quinson AM, Stern JO, Omata M.
PMID: 27153246
Hepatol Res. 2017 Mar;47(3):E142-E151. doi: 10.1111/hepr.12741. Epub 2016 Aug 10.

AIM: We evaluated the safety and efficacy of the hepatitis C virus (HCV) NS3/4A A protease inhibitor faldaprevir plus pegylated interferon α-2b and ribavirin (PegIFNα-2b/RBV) in Japanese patients with HCV genotype-1 infection.METHODS: Treatment-naïve patients were randomized (1:1) to faldaprevir...

Cite
Nishiguchi S, Urano Y, Suzaki K, et al. Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection. Hepatol Res. 2016;47(3):E142-E151doi: 10.1111/hepr.12741.
Nishiguchi, S., Urano, Y., Suzaki, K., Taniguchi, A., Scherer, J., Berger, K. L., Quinson, A. M., Stern, J. O., & Omata, M. (2017). Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection. Hepatology research : the official journal of the Japan Society of Hepatology, 47(3), E142-E151. https://doi.org/10.1111/hepr.12741
Nishiguchi, Shuhei, et al. "Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection." Hepatology research : the official journal of the Japan Society of Hepatology vol. 47,3 (2017): E142-E151. doi: https://doi.org/10.1111/hepr.12741
Nishiguchi S, Urano Y, Suzaki K, Taniguchi A, Scherer J, Berger KL, Quinson AM, Stern JO, Omata M. Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection. Hepatol Res. 2017 Mar;47(3):E142-E151. doi: 10.1111/hepr.12741. Epub 2016 Aug 10. PMID: 27153246.
Copy Download .nbib Format: NLM
Large Renal Calculus.

The Indian medical gazette

Steen HB.
PMID: 29005440
Ind Med Gaz. 1912 Aug;47(8):320.

No abstract available.

Cite
Steen HB. Large Renal Calculus. Ind Med Gaz. 1912;47(8):320
Steen, H. B. (1912). Large Renal Calculus. The Indian medical gazette, 47(8), 320.
Steen, H B. "Large Renal Calculus." The Indian medical gazette vol. 47,8 (1912): 320.
Steen HB. Large Renal Calculus. Ind Med Gaz. 1912 Aug;47(8):320. PMID: 29005440; PMCID: PMC5168281.
Copy Download .nbib Format: NLM
A Case of Faciolopsis Buski: (Distoma Buski .

The Indian medical gazette

Steen HB.
PMID: 29004996
Ind Med Gaz. 1907 Oct;42(10):376.

No abstract available.

Cite
Steen HB. A Case of Faciolopsis Buski: (Distoma Buski . Ind Med Gaz. 1907;42(10):376
Steen, H. B. (1907). A Case of Faciolopsis Buski: (Distoma Buski . The Indian medical gazette, 42(10), 376.
Steen, H B. "A Case of Faciolopsis Buski: (Distoma Buski ." The Indian medical gazette vol. 42,10 (1907): 376.
Steen HB. A Case of Faciolopsis Buski: (Distoma Buski . Ind Med Gaz. 1907 Oct;42(10):376. PMID: 29004996; PMCID: PMC5165857.
Copy Download .nbib Format: NLM
Self-biasing of carrier depletion based silicon microring modulators.

Optics express

Melikyan A, Kim K, Stern B, Kaneda N.
PMID: 32752513
Opt Express. 2020 Jul 20;28(15):22540-22548. doi: 10.1364/OE.395182.

We report on the self-biasing effect of carrier depletion based silicon microring modulators (MRM) by demonstrating that a silicon MRM can generate open eye diagrams for non-return-to-zero (NRZ) on-off keying (OOK) modulation without an external reverse bias supplied to...

Cite
Melikyan A, Kim K, Stern B, et al. Self-biasing of carrier depletion based silicon microring modulators. Opt Express. 2020;28(15):22540-22548doi: 10.1364/OE.395182.
Melikyan, A., Kim, K., Stern, B., & Kaneda, N. (2020). Self-biasing of carrier depletion based silicon microring modulators. Optics express, 28(15), 22540-22548. https://doi.org/10.1364/OE.395182
Melikyan, Argishti, et al. "Self-biasing of carrier depletion based silicon microring modulators." Optics express vol. 28,15 (2020): 22540-22548. doi: https://doi.org/10.1364/OE.395182
Melikyan A, Kim K, Stern B, Kaneda N. Self-biasing of carrier depletion based silicon microring modulators. Opt Express. 2020 Jul 20;28(15):22540-22548. doi: 10.1364/OE.395182. PMID: 32752513.
Copy Download .nbib Format: NLM
Reinventing postgraduate training in the plant sciences: T-training defined through modularity, customization, and distributed mentorship.

Plant direct

Henkhaus NA, Taylor CB, Greenlee VR, Sickler DB, Stern DB.
PMID: 31245696
Plant Direct. 2018 Nov 20;2(11):e00095. doi: 10.1002/pld3.95. eCollection 2018 Nov.

The Plant Science Research Network (PSRN) comprises scientific societies and organizations with a mission to build and communicate a consensus vision of the future of plant science research, education, and training. This report enumerates a set of far-reaching recommendations...

Cite
Henkhaus NA, Taylor CB, Greenlee VR, et al. Reinventing postgraduate training in the plant sciences: T-training defined through modularity, customization, and distributed mentorship. Plant Direct. 2018;2(11):e00095doi: 10.1002/pld3.95.
Henkhaus, N. A., Taylor, C. B., Greenlee, V. R., Sickler, D. B., & Stern, D. B. (2018). Reinventing postgraduate training in the plant sciences: T-training defined through modularity, customization, and distributed mentorship. Plant direct, 2(11), e00095. https://doi.org/10.1002/pld3.95
Henkhaus, Natalie A, et al. "Reinventing postgraduate training in the plant sciences: T-training defined through modularity, customization, and distributed mentorship." Plant direct vol. 2,11 (2018): e00095. doi: https://doi.org/10.1002/pld3.95
Henkhaus NA, Taylor CB, Greenlee VR, Sickler DB, Stern DB. Reinventing postgraduate training in the plant sciences: T-training defined through modularity, customization, and distributed mentorship. Plant Direct. 2018 Nov 20;2(11):e00095. doi: 10.1002/pld3.95. eCollection 2018 Nov. PMID: 31245696; PMCID: PMC6508785.
Copy Download .nbib Format: NLM
Quality of web-based information at the beginning of a global pandemic: a cross-sectional infodemiology study investigating preventive measures and self care methods of the coronavirus disease 2019.

BMC public health

Stern J, Georgsson S, Carlsson T.
PMID: 34126962
BMC Public Health. 2021 Jun 14;21(1):1141. doi: 10.1186/s12889-021-11141-9.

BACKGROUND: reducing the spread and impact epidemics and pandemics requires that members of the general population change their behaviors according to the recommendations, restrictions and laws provided by leading authorities. When a new epidemic or pandemic emerges, people are...

Cite
Stern J, Georgsson S, Carlsson T. Quality of web-based information at the beginning of a global pandemic: a cross-sectional infodemiology study investigating preventive measures and self care methods of the coronavirus disease 2019. BMC Public Health. 2021;21(1):1141doi: 10.1186/s12889-021-11141-9.
Stern, J., Georgsson, S., & Carlsson, T. (2021). Quality of web-based information at the beginning of a global pandemic: a cross-sectional infodemiology study investigating preventive measures and self care methods of the coronavirus disease 2019. BMC public health, 21(1), 1141. https://doi.org/10.1186/s12889-021-11141-9
Stern, Jenny, et al. "Quality of web-based information at the beginning of a global pandemic: a cross-sectional infodemiology study investigating preventive measures and self care methods of the coronavirus disease 2019." BMC public health vol. 21,1 (2021): 1141. doi: https://doi.org/10.1186/s12889-021-11141-9
Stern J, Georgsson S, Carlsson T. Quality of web-based information at the beginning of a global pandemic: a cross-sectional infodemiology study investigating preventive measures and self care methods of the coronavirus disease 2019. BMC Public Health. 2021 Jun 14;21(1):1141. doi: 10.1186/s12889-021-11141-9. PMID: 34126962; PMCID: PMC8201436.
Copy Download .nbib Format: NLM
Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.

Genes

Dehner CA, Armstrong AE, Yohe M, Shern JF, Hirbe AC.
PMID: 34680895
Genes (Basel). 2021 Sep 25;12(10). doi: 10.3390/genes12101500.

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and adolescents and accounts for approximately 2% of soft tissue sarcomas in adults. It is subcategorized into distinct subtypes based on histological features and fusion status (

Cite
Dehner CA, Armstrong AE, Yohe M, et al. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma. Genes (Basel). 2021;12(10)doi: 10.3390/genes12101500.
Dehner, C. A., Armstrong, A. E., Yohe, M., Shern, J. F., & Hirbe, A. C. (2021). Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma. Genes, 12(10), . https://doi.org/10.3390/genes12101500
Dehner, Carina A, et al. "Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma." Genes vol. 12,10 (2021). doi: https://doi.org/10.3390/genes12101500
Dehner CA, Armstrong AE, Yohe M, Shern JF, Hirbe AC. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma. Genes (Basel). 2021 Sep 25;12(10). doi: 10.3390/genes12101500. PMID: 34680895; PMCID: PMC8535289.
Copy Download .nbib Format: NLM
Showing 373 to 384 of 403 entries